Literature DB >> 6491081

Left ventricular dysfunction after acute myocardial infarction: results of a prospective multicenter study.

H Greenberg, P McMaster, E M Dwyer.   

Abstract

In a multicenter prospective study of 866 patients who survived the coronary care unit phase of an acute myocardial infarction, variables reflecting left ventricular function were examined to assess their impact on 2 year survival. Single variables that reflected left ventricular dysfunction before infarction and in the acute and recovery phases were, respectively, history of prior myocardial infarction, rales in the coronary care unit dichotomized at greater than bibasilar and predischarge radionuclide ejection fraction dichotomized at less than 0.40. When combined in a stepwise fashion, patients lacking these three risk characteristics had a 2 year 4.2% mortality rate, whereas patients possessing all three characteristics had a 45% mortality rate. Rales in the coronary care unit and predischarge ejection fraction act independently, and each contributes to mortality. Fifty-two patients with advanced rales but an ejection fraction of 0.40 or greater had a 21% mortality rate. Similarly, 208 patients with few rales but an ejection fraction of less than 0.40 had a 15% mortality rate. These data suggest that the mortality risk imposed by those factors that assess permanent left ventricular damage is independent of and additive to the mortality risk contributed by dynamic, acute phase dysfunction. These data fit the hypothesis that acute phase dysfunction is, in part, due to transient ischemia that, on reversal, can restore function toward normal. The results suggest 1) that assessment of left ventricular function during the acute and recovery phases of myocardial infarction is necessary to define prognostic characteristics of an individual patient, and 2) that of particular importance is the identification of patients whose postinfarction course is consistent with reversible ischemia.

Entities:  

Mesh:

Year:  1984        PMID: 6491081     DOI: 10.1016/s0735-1097(84)80045-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  18 in total

Review 1.  Measurement of ventricular function with radionuclide techniques.

Authors:  Kim A Williams
Journal:  Curr Cardiol Rep       Date:  2003-01       Impact factor: 2.931

2.  Gated planar technetium 99m-labeled sestamibi myocardial perfusion image inversion for quantitative scintigraphic assessment of left ventricular function.

Authors:  K A Williams; L A Taillon
Journal:  J Nucl Cardiol       Date:  1995 Jul-Aug       Impact factor: 5.952

Review 3.  Stratifying risk after a myocardial infarction.

Authors:  N F Goldschlager
Journal:  West J Med       Date:  1988-07

4.  Prognostic value of predischarge radionuclide ventriculography at rest and exercise after acute myocardial infarction treated with thrombolytic therapy or primary coronary angioplasty. The Zwolle Myocardial Infarction Study Group.

Authors:  A T Gosselink; A L Liem; S Reiffers; F Zijlstra
Journal:  Clin Cardiol       Date:  1998-04       Impact factor: 2.882

5.  The mortality risk associated with digitalis treatment after myocardial infarction.

Authors:  A J Moss; J T Bigger; E Carleen; J L Fleiss; C L Odoroff; L Rolnitzky; T Therneau
Journal:  Cardiovasc Drugs Ther       Date:  1987-08       Impact factor: 3.727

Review 6.  Ventricular arrhythmias in congestive heart failure: clinical significance and management.

Authors:  G R Khoshnevis; A Massumi
Journal:  Tex Heart Inst J       Date:  1999

7.  The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse.

Authors:  Eleonora Mezzaroma; Stefano Toldo; Daniela Farkas; Ignacio M Seropian; Benjamin W Van Tassell; Fadi N Salloum; Harsha R Kannan; Angela C Menna; Norbert F Voelkel; Antonio Abbate
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-21       Impact factor: 11.205

Review 8.  Role of single photon wall motion and perfusion studies in the evaluation of patients with suspected coronary artery disease.

Authors:  H Yaoita; H W Strauss
Journal:  Eur J Nucl Med       Date:  1990

Review 9.  Cost effectiveness of implantable cardioverter defibrillator therapy versus drug therapy for patients at high risk of sudden cardiac death.

Authors:  Marian A Spath; Bernie J O'Brien
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 10.  Beta-blockers and calcium antagonists in angina pectoris. The potential role of combination therapy.

Authors:  H J Dargie
Journal:  Drugs       Date:  1988       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.